Cargando…
The Innovative Medicines Initiative: a Public Private Partnership Model to Foster Drug Discovery
The Innovative Medicines Initiative (IMI) is a large-scale public–private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI aims to boost the development of new medicines across Europe by implementing new collaborative...
Autor principal: | Vaudano, Elisabetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology (RNCSB) Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962198/ https://www.ncbi.nlm.nih.gov/pubmed/24688725 http://dx.doi.org/10.5936/csbj.201303017 |
Ejemplares similares
-
Public–private partnerships in fostering outer space innovations
por: Rausser, Gordon, et al.
Publicado: (2023) -
Public-private partnerships as driving forces in the quest for innovative medicines
por: Goldman, Michel, et al.
Publicado: (2013) -
Data sharing in neurodegenerative disease research: challenges and learnings from the innovative medicines initiative public-private partnership model
por: Bradshaw, Angela, et al.
Publicado: (2023) -
Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare
por: de Vrueh, Remco L. A., et al.
Publicado: (2019) -
The European Lead Factory: A Blueprint for Public–Private Partnerships in Early Drug Discovery
por: Karawajczyk, Anna, et al.
Publicado: (2017)